NewsBlaze search box Daily News header

Does an Aspirin A Day Keep Colon Cancer Away?

By  

Most people already know that a dose of "baby" aspirin taken each day is beneficial for many older people's health because it reduces the chance of a heart attack and some kinds of strokes but a new study out of the UK by Professor Peter Rothwell, John Radcliffe Hospital, Oxford, and University of Oxford, UK, and colleagues shows benefits related to colorectal cancer.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61543-7/abstract

Previous studies showed that high doses (>500mg) day were beneficial but daily high doses can be dangerous because aspirin can cause stomach bleeding and other problems.

The new study indicates that even at low doses people over 40 years-of-age will see a 25% reduction in colon cancer if they take a baby aspirin every day.

Long term use also reduces mortality (death rate) due to proximal colon cancer.

"Aspirin taken for several years at doses of at least 75 mg daily reduced long-term incidence and mortality due to colorectal cancer. Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy."

There is a discussion on the Lancet Facebook page.

John McCormick is a reporter, /science/medical columnist and finance and social commentator, with 17,000+ bylined stories. Contact John through NewsBlaze.

  Please leave a comment here     If it does not display within 10 seconds, please refresh the page

Related Health News

The on again, off again concerns over avian flu spreading to humans are on again with breaking news from China of human-human transmission.
It is believed the birth defect (microcephaly, meaning small head) occurring in large numbers in Brazil is caused by the Zika virus, carried by a mosquito.
The extent of smoking promotion was revealed following the release of documents from old, previously sealed anti-smoking court cases.
Depression, bipolar disorder, ADHD and mood and behavior conditions exist. Were they over-diagnosed and over-treated when the expensive pills were covered by patents?
Seventeen-year-old Science Fair Winner develops a $25, fast, easy test for Ebola. The Ebola epidemic is over but an easy-to-use test is still critical.
Medecins Sans Frontieres reports that antimalarial drug, artesunate-amodiaquine vs artemether-lumefantrine greatly improved Ebola patient survival.

 

NewsBlaze Writers Of The Month


Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2016 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site